Engene Holdings Warrants Stock Today
| ENGNW Stock | 0.81 0.04 4.71% |
Performance0 of 100
| Odds Of DistressOver 70
|
EnGene Holdings is selling for under 0.81 as of the 18th of January 2025; that is 4.71 percent down since the beginning of the trading day. The stock's lowest day price was 0.81. EnGene Holdings has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of October 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of November 2023 | Category Healthcare | Classification Health Care |
EnGene Holdings is entity of United States. It is traded as Stock on NASDAQ exchange. More on enGene Holdings Warrants
Moving against EnGene Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
EnGene Stock Highlights
| CEO Director | JD Esq | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
EnGene Holdings can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand EnGene Holdings' financial leverage. It provides some insight into what part of EnGene Holdings' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
enGene Holdings Warrants (ENGNW) is traded on NASDAQ Exchange in USA. It is located in 4868 Rue Levy, Montreal, QC, Canada, H4R 2P1 and employs 31 people. EnGene Holdings is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
EnGene Holdings generates negative cash flow from operations
Check EnGene Holdings Probability Of Bankruptcy
EnGene Holdings Historical Income Statement
EnGene Stock Against Markets
EnGene Holdings Corporate Executives
Elected by the shareholders, the EnGene Holdings' board of directors comprises two types of representatives: EnGene Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnGene. The board's role is to monitor EnGene Holdings' management team and ensure that shareholders' interests are well served. EnGene Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnGene Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| DSc FRSC | CoFounder Board | Profile | |
| Anthony Cheung | CoFounder Officer | Profile | |
| David Daws | CFO Development | Profile |
Additional Tools for EnGene Stock Analysis
When running EnGene Holdings' price analysis, check to measure EnGene Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnGene Holdings is operating at the current time. Most of EnGene Holdings' value examination focuses on studying past and present price action to predict the probability of EnGene Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnGene Holdings' price. Additionally, you may evaluate how the addition of EnGene Holdings to your portfolios can decrease your overall portfolio volatility.